NEW QUALIFIED HEALTH CLAIM for magnesium and reduced risk of high blood pressure

Jan 13, 2022

Dear Colleagues —

I am pleased to inform you that on January 10 the FDA issued the attached constituent update advising the Center for Magnesium Education and Research that FDA is authorizing three qualified health claims regarding the relationship between consumption of magnesium and the reduced risk of high blood pressure.

As you will see in the constituent letter, FDA is allowing three separate qualified health claims that may be used on labels and labeling, provided the text of each claim is used just as FDA has stated.

We congratulate Mr. Johnson and the Center for Magnesium Education and Research for their efforts to have these qualified health claims recognized by FDA. On a personal note, I take magnesium daily as many others do and now hope that the great benefits of magnesium will come to broader public attention.

Finally, FDA’s response letter is 42 pages long and provides an exhaustive review of the literature and the rationale for establishing the claims as they did. This is a very useful document. We encourage you to review it, should you now choose to use one or all of these qualified health claims.



UNPA visits the “Herbal Cowboy”, and the Case Mill Homestead
Aug 18, 2020
mark blumenthal abc american botanical council

You all know him as the Herbal Cowboy. I am new in town (to the herbs and natural products industry) so I approached


UNPA received the Market Development Cooperator Program (MDCP) award from the U.S. Department of Commerce’s International Trade Administration (ITA)
Jan 27, 2021

Since 2017, UNPA has broadly engaged Chinese peer associations, chambers of commerce, and other organizations to assess the opportunity to assist US companies


UNPA’s Israelsen on DSHEA 2.0 & CBD: ‘Unless there is unity, it just gets harder’
Apr 29, 2021
nutraingredients loren israelsen interview dshea cbd unity dietary supplements health and education act stephen daniells video

Proposed modernizations to the Dietary Supplement Health and Education Act (DSHEA) and solutions to the CBD issue require “an outstanding effort by industry